InspireMD Inc
NASDAQ:NSPR

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
NASDAQ:NSPR
Watchlist
Price: 2.37 USD -0.84%
Market Cap: 72.6m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

NSPR doesn't have a meaningful market cap.

The Relative Value of one NSPR stock under the Base Case scenario is 4.46 USD. Compared to the current market price of 2.37 USD, InspireMD Inc is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NSPR Relative Value
Base Case
4.46 USD
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.1
P/S
P/S
Price to Sales
10.1
vs History
30
vs Industry
12
Median 3Y
9.8
Median 5Y
9.4
Industry
2.4
Forward
9.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
22.5
Forward
-2.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-3
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3
Median 5Y
-2.8
Industry
20.4
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
9
vs Industry
47
Median 3Y
1.5
Median 5Y
1.2
Industry
2.2
More Details
8.2
EV/S
EV/S
Enterprise Value to Sales
8.2
vs History
11
vs Industry
26
Median 3Y
3.4
Median 5Y
1.2
Industry
2.6
Forward
7.8
More Details
38.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
38.1
vs History
11
vs Industry
10
Median 3Y
13
Median 5Y
4.3
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
56
Median 3Y
-0.9
Median 5Y
-0.3
Industry
11.9
Forward
-1.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
53
Median 3Y
-0.9
Median 5Y
-0.3
Industry
16.3
Forward
25.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
58
Median 3Y
-1.2
Median 5Y
-0.4
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
47
Median 3Y
-1.2
Median 5Y
-0.4
Industry
17.9
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
38
vs Industry
24
Median 3Y
2.7
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

NSPR Competitors Multiples
InspireMD Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
InspireMD Inc
NASDAQ:NSPR
71.1m USD 10.1 -2 -1.5 -1.5
JP
Hoya Corp
TSE:7741
6.6T JPY 7.6 32.7 20.4 24.3
CH
Alcon AG
SIX:ALC
34.2B CHF 4.3 37.9 17.5 33
DK
Coloplast A/S
CSE:COLO B
136.6B DKK 4.9 30.1 17.4 20.5
US
Align Technology Inc
NASDAQ:ALGN
10.1B USD 2.5 23 11.6 14.3
CH
Ypsomed Holding AG
SIX:YPSN
5.3B CHF 7.1 60.7 29.3 50.3
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.4 224.1 364
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
43.3B CNY 12.3 31 26.7 26.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.1B USD 3.5 42.5 18.9 33.8
CA
Bausch + Lomb Corp
NYSE:BLCO
4.8B USD 1 -17.9 18 94.8
JP
Asahi Intecc Co Ltd
TSE:7747
665.1B JPY 5.6 63.2 16.1 22
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
InspireMD Inc
NASDAQ:NSPR
Average EV/EBITDA: 40
Negative Multiple: -1.5 		N/A N/A
JP
Hoya Corp
TSE:7741
20.4
9%
2.3
CH
Alcon AG
SIX:ALC
17.5
10%
1.7
DK
Coloplast A/S
CSE:COLO B
17.4
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
11.6
15%
0.8
CH
Ypsomed Holding AG
SIX:YPSN
29.3
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
224.1
11%
20.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.7
18%
1.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.9
12%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
18
19%
0.9
JP
A
Asahi Intecc Co Ltd
TSE:7747
16.1
11%
1.5

See Also

Summary
NSPR intrinsic value, competitors valuation, and company profile.
DCF Valuation
NSPR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NSPR stock valuation using valuation multiples.
Wall Street Estimates
NSPR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NSPR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 273,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.